Literature DB >> 22337965

Evaluation of primary opioid receptor antibodies for use in western blotting.

H Niwa, D J Rowbotham, D G Lambert.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22337965     DOI： 10.1093/bja/aes015

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  8 in total

1.  Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.

Authors:  Franck Talmont; Lionel Moulédous
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-01-24       Impact factor: 3.000

2.  Morphine decreases enteric neuron excitability via inhibition of sodium channels.

Authors:  Tricia H Smith; John R Grider; William L Dewey; Hamid I Akbarali
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

3.  Denatured G-protein coupled receptors as immunogens to generate highly specific antibodies.

Authors:  Franck Talmont; Lionel Moulédous; Jérôme Boué; Catherine Mollereau; Gilles Dietrich
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

4.  The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.

Authors:  Zoë L S Brookes; Emily N Stedman; Nicola J Brown; Christopher P Hebbes; Remo Guerrini; Girolamo Calo; Charles S Reilly; David G Lambert
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

5.  μ-Opioid receptor antibody reveals tissue-dependent specific staining and increased neuronal μ-receptor immunoreactivity at the injured nerve trunk in mice.

Authors:  Yvonne Schmidt; Claire Gavériaux-Ruff; Halina Machelska
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

6.  Functional and structural characterization of axonal opioid receptors as targets for analgesia.

Authors:  Egle M Mambretti; Katrin Kistner; Stefanie Mayer; Dominique Massotte; Brigitte L Kieffer; Carsten Hoffmann; Peter W Reeh; Alexander Brack; Esther Asan; Heike L Rittner
Journal:  Mol Pain       Date:  2016-03-01       Impact factor: 3.395

7.  Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor.

Authors:  M F Bird; R Guerrini; J M Willets; J P Thompson; G Caló; D G Lambert
Journal:  Br J Pharmacol       Date:  2018-11-06       Impact factor: 8.739

Review 8.  Opioid Receptors in Immune and Glial Cells-Implications for Pain Control.

Authors:  Halina Machelska; Melih Ö Celik
Journal:  Front Immunol       Date:  2020-03-04       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.